SCHEMBL20127565

SCHEMBL20127565

c1cc(-c2ccc3c4ccccc4c4ccccc4c3c2)cc(-c2c3ccccc3c(-c3ccc4c(c3)oc3cc5ccccc5cc34)c3ccccc23)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.36
ESR1 P03372 4/20 0.36
ESR2 Q92731 4/20 0.36
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
PLA2G10 O15496 1/20 0.35
AHR P35869 2/20 0.35
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 3/20 0.34
MEN1 O00255 2/20 0.34
HPGD P15428 2/20 0.34
KMT2A Q03164 2/20 0.34
ALOX5 P09917 1/20 0.33
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
HSD17B1 P14061 2/20 0.33
HSD17B2 P37059 2/20 0.33
DUSP3 P51452 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17246938 0.94 PLA2G2A (0.41) HCRTR1ESR1ESR2PLA2G2APLA2G4A
SCHEMBL20127548 0.94 AHR (0.39) HCRTR1ESR1ESR2AHRKDM4E
SCHEMBL20127569 0.93 PLA2G2A (0.43) HCRTR1ESR1ESR2PLA2G2APLA2G4A
SCHEMBL16067726 0.93 ESR1 (0.43) HCRTR1ESR1ESR2PLA2G2APLA2G4A
SCHEMBL16067821 0.93 ESR1 (0.40) HCRTR1ESR1ESR2PLA2G2APLA2G4A
SCHEMBL20127561 0.93 HCRTR1 (0.36) HCRTR1ESR1ESR2PLA2G2APLA2G4A
SCHEMBL22260567 0.92 ESR1 (0.37) HCRTR1ESR1ESR2PLA2G2APLA2G4A
SCHEMBL16067708 0.91 HSD17B1 (0.41) HCRTR1ESR1ESR2PLA2G2APLA2G4A
SCHEMBL16067842 0.91 HSD17B1 (0.41) HCRTR1ESR1ESR2PLA2G2APLA2G4A
SCHEMBL16067672 0.90 PLA2G2A (0.45) HCRTR1ESR1ESR2PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 HCRTR1 1635/4885ESR1 152/4885ESR2 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.